Gene Therapy Firm Freeline Successfully Tops Up Series C

CEO Says $120m Financing Will Advance Key Clinical Programs

 
• By Sten Stovall
  
DNA
Freeline is developing curative gene therapies for chronic systemic disease. • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip